Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Gene Therapy Market to reach USD 24.3billion by the end of 2029

Global Gene Therapy Market Size study & Forecast, by Vector [Viral VectorsNon-viral VectorsBy Delivery Method (In Vivo, Ex Vivo) by Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Others), By Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Receptors, Others), and Regional Analysis, 2022-2029

Product Code: HLSB-49585345
Publish Date: 20-03-2023
Page: 200

Global Gene Therapy Market is valued at approximately USD 6.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 18.6% over the forecast period 2021-2029. An instruction set for a certain function is carried by a gene, a functional hereditary unit of life. The most cutting-edge treatment for blood disorders, chronic illnesses, infectious diseases, and cancer is gene therapy. The term “gene therapy” refers to the process of treating a disease by altering, substituting, or enhancing a missing or deficient genetic combination that causes the ailment. To treat or stop the spread of disease, gene therapy entails replacing some or all of a patient’s body’s damaged genes with healthy ones. Globally rising rates of cancer, uncommon diseases, genetic disorders, and other medical conditions are the major factors fueling the growth of the gene therapy market.

Over the past few years, gene therapy research has gained more attention. Many businesses introduce cutting-edge products to capitalize on market growth prospects. A researcher from the Indiana University School of Medicine received a USD 12 million grant from the national heart, lung, and blood institute in March 2022. The grant will be used to investigate key ideas in a gene therapy strategy for more effective and potentially curative hemophilia therapies. A robust product portfolio, increasing investments by major market participants, a high prevalence of the target diseases, and interest in novel and creative therapies are some factors that affect the growth of the gene therapy industry. In developed nations, sophisticated therapeutic approaches to chronic disorders are being applied. As a result, chemotherapy and other conventional treatment modalities that have unfavorable side effects and long-term consequences are being substituted with this one. Viral vectors, which have low toxicity and high immunogenicity, are increasingly being used in the production of such medications.The high cost of gene treatments, however, is anticipated to somewhat restrain market expansion throughout the forecast period.

The key regions considered for the Global Gene Therapy Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America segment dominated the global gene therapy market in 2020, in terms of revenue, and is estimated to maintain its dominance during the forecast period. Several government organizations are supporting research campaigns around the country, owing to the robust regulatory framework for cellular treatment development and the substantial presence of biopharmaceutical businesses. Europe is expected to grow with the highest CAGR during the forecast period, the availability of reimbursements, the presence of key industry players in the area, and the existence of contemporary healthcare infrastructure are all essential factors promoting the expansion of the gene therapy market in Europe.

Major market player included in this report are:
Amgen Inc.
Biogen Inc.
Bluebird Bio Inc.
Gilead Sciences Inc. (Kite Pharma)
Novartis AG
Orchard Therapeutics
Sibiono GeneTech Co. Ltd
Hoffmann-La Roche Ltd (Spark Therapeutics)
UniQure NV
Abeona Therapeutics Inc.
Recent Developments in the Market:
 Sarepta Therapeutics (US) established a partnership with GenEdit in February 2022 to create gene-editing therapeutics to treat neuromuscular illnesses using Sarepta’s technology and GenEdit’s NanoGalaxy platform.
 The FDA approved KYMRIAH for adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in May 2022 from Novartis AG (Switzerland).

Global Gene Therapy Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered vectors, Delivery Method, Application, Gene Type, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Vectors:
Viral Vectors
Non-viral Vectors

By Delivery Method:
In Vivo
Ex Vivo

By Application:
Oncological Disorders
Rare Diseases
Cardiovascular Diseases
Neurological Disorders
Infectious Diseases
Others

By Gene Type:
Antigen
Cytokine
Tumor Suppressor
Suicide
Deficiency
Receptors
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
South Korea
RoAPAC
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Gene Therapy Market, by Region, 2019-2029 (USD Billion)
1.2.2. Gene Therapy Market, by vector, 2019-2029 (USD Billion)
1.2.3. Gene Therapy Market, by Delivery Method, 2019-2029 (USD Billion)
1.2.4. Gene Therapy Market, by Application, 2019-2029 (USD Billion)
1.2.5. Gene Therapy Market, by Gene Type, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Gene Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Gene Therapy Market Dynamics
3.1. Gene Therapy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Globally rising rates of Cancer and Genetic Diseases
3.1.1.2. Increasing Investment by major Market Players
3.1.2. Market Challenges
3.1.2.1. High Cost of Gene Therapy
3.1.3. Market Opportunities
3.1.3.1. Research and Development of Gene Therapy
Chapter 4. Global Gene Therapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Gene Therapy Market, by vector
6.1. Market Snapshot
6.2. Global Gene Therapy Market by vector, Performance – Potential Analysis
6.3. Global Gene Therapy Market Estimates & Forecasts by vector 2019-2029 (USD Billion)
6.4. Gene Therapy Market, Sub Segment Analysis
6.4.1. Viral Vectors
6.4.2. Non-viral Vectors
Chapter 7. Global Gene Therapy Market, by Delivery Method
7.1. Market Snapshot
7.2. Global Gene Therapy Market by Delivery Method, Performance – Potential Analysis
7.3. Global Gene Therapy Market Estimates & Forecasts by Delivery Method 2019-2029 (USD Billion)
7.4. Gene Therapy Market, Sub Segment Analysis
7.4.1. In Vivo
7.4.2. Ex Vivo
Chapter 8. Global Gene Therapy Market, by Application
8.1. Market Snapshot
8.2. Global Gene Therapy Market by Application, Performance – Potential Analysis
8.3. Global Gene Therapy Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
8.4. Gene Therapy Market, Sub Segment Analysis
8.4.1. Oncological Disorders
8.4.2. Rare Diseases
8.4.3. Cardiovascular Diseases
8.4.4. Neurological Disorders
8.4.5. Infectious Diseases
8.4.6. Others
Chapter 9. Global Gene Therapy Market, by Gene Type
9.1. Market Snapshot
9.2. Global Gene Therapy Market by Gene Type, Performance – Potential Analysis
9.3. Global Gene Therapy Market Estimates & Forecasts by Gene Type 2019-2029 (USD Billion)
9.4. Gene Therapy Market, Sub Segment Analysis
9.4.1. Antigen
9.4.2. Cytokine
9.4.3. Tumor Suppressor
9.4.4. Suicide
9.4.5. Deficiency
9.4.6. Receptors
9.4.7. Others
Chapter 10. Global Gene Therapy Market, Regional Analysis
10.1. Gene Therapy Market, Regional Market Snapshot
10.2. North America Gene Therapy Market
10.2.1. U.S. Gene Therapy Market
10.2.1.1. vector breakdown estimates & forecasts, 2019-2029
10.2.1.2. Delivery Method breakdown estimates & forecasts, 2019-2029
10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
10.2.1.4. Gene Type breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Gene Therapy Market
10.3. Europe Gene Therapy Market Snapshot
10.3.1. U.K. Gene Therapy Market
10.3.2. Germany Gene Therapy Market
10.3.3. France Gene Therapy Market
10.3.4. Spain Gene Therapy Market
10.3.5. Italy Gene Therapy Market
10.3.6. Rest of Europe Gene Therapy Market
10.4. Asia-Pacific Gene Therapy Market Snapshot
10.4.1. China Gene Therapy Market
10.4.2. India Gene Therapy Market
10.4.3. Japan Gene Therapy Market
10.4.4. Australia Gene Therapy Market
10.4.5. South Korea Gene Therapy Market
10.4.6. Rest of Asia Pacific Gene Therapy Market
10.5. Latin America Gene Therapy Market Snapshot
10.5.1. Brazil Gene Therapy Market
10.5.2. Mexico Gene Therapy Market
10.6. Rest of The World Gene Therapy Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Amgen Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Biogen Inc.
11.2.3. Bluebird Bio Inc.
11.2.4. Gilead Sciences Inc. (Kite Pharma)
11.2.5. Novartis AG
11.2.6. Orchard Therapeutics
11.2.7. Sibiono GeneTech Co. Ltd
11.2.8. Hoffmann-La Roche Ltd (Spark Therapeutics)
11.2.9. UniQure NV
11.2.10. Abeona Therapeutics Inc
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now